Skip to main content
    O

    Omada Health, Inc. Common Stock (OMDA)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $14.33
    -0.37 (-2.52%)

    Market Cap: $889.00M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Omada Health, Inc. Common Stock (OMDA) Financials: Revenue, Profit and Cash Flow

    Updated Nov 5, 2026. Financial statements from company filings, amounts in US dollars.

    Omada Health, Inc. Common Stock reported revenue of $260.21M for the fiscal year ended Dec 31, 2025, up 53.2% from the year before. That year, net income was -$12.78M with a net margin of -4.9%, operating cash flow was $18.25M and free cash flow was $12.42M. The quarter ended Sep 30, 2026 had revenue of $91.31M and net income of $6.55M.

    Revenue and Margins

    The operating margin was -4.6% in the fiscal year ended Dec 2025, the highest of the 4 years shown.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$260.21M+53.2%65.7%-4.6%-4.9%
    Dec 2024$169.80M+38.3%60.6%-25.7%-27.8%
    Dec 2023$122.78M+37.7%57.0%-53.8%-55.0%
    Dec 2022$89.19MN/A48.0%-81.1%-81.3%
    Annual, fiscal years ended Dec 2022 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Sep 2026, net income turned positive after a loss in the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022
    Revenue$260.21M$169.80M$122.78M$89.19M
    Cost of revenue$89.27M$66.92M$52.81M$46.39M
    Gross profit$170.94M$102.88M$69.97M$42.79M
    Research and development$40.68M$35.92M$33.74M$26.17M
    Operating income-$11.97M-$43.65M-$66.00M-$72.35M
    Net income-$12.78M-$47.14M-$67.51M-$72.52M
    EBITDA-$4.33M-$35.60M-$60.38M-$63.99M
    Fiscal years ended Dec 2022 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$91.31M$87.83M$78.05M$75.85M$68.03M$61.37M$54.96M$47.98M$45.52M$41.21M$35.09M$32.55M
    Gross profit$69.28M$63.79M$48.69M$53.66M$45.07M$40.31M$31.90M$31.98M$28.56M$24.83M$17.35M$20.10M
    Operating income$4.82M$3.55M-$4.78M$3.28M-$2.51M-$4.34M-$8.40M-$7.10M-$8.52M-$10.04M-$17.99M-$13.40M
    Net income$6.55M$5.29M-$2.97M$5.16M-$3.18M-$5.31M-$9.45M-$8.25M-$9.23M-$10.69M-$18.97M-$13.93M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents of $222.04M were 72.7% of total assets of $305.41M, against total liabilities of $75.73M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022
    Total assets$305.41M$150.89M$175.08M$221.80M
    Current assets$272.93M$113.06M$142.88M$188.56M
    Cash and equivalents$222.04M$76.39M$115.64M$168.12M
    Total liabilities$75.73M$86.26M$76.16M$66.19M
    Short-term debtN/A$415.00K$787.00K$648.00K
    Long-term debtN/A$29.77M$29.38M$28.89M
    Shareholder equity$229.68M-$384.40M$98.92M$155.60M
    Fiscal years ended Dec 2022 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$348.54M$328.22M$302.80M$305.41M$287.47M$302.97M$141.18MN/AN/AN/AN/AN/A
    Total liabilities$75.38M$75.48M$68.68M$75.73M$70.12M$88.76M$82.20M$535.29MN/AN/A-$98.92MN/A
    Cash and equivalents$243.15M$221.71M$211.76M$222.04M$198.63M$223.15M$59.40MN/AN/AN/A$115.67MN/A
    Shareholder equity$273.16M$252.74M$234.12M$229.68M$217.35M$214.21M$58.98M-$384.40MN/AN/A$98.92MN/A
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 68.1% of operating cash flow. Share repurchases came to 34.5% of it.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022
    Operating cash flow$18.25M-$34.18M-$49.74M-$68.98M
    Capital expenditures$5.83M$3.86M$2.92M$2.72M
    Free cash flow$12.42M-$38.04M-$52.66M-$71.70M
    Share repurchases$4.28M$4.54M$111.00KN/A
    Investing cash flow-$5.83M-$3.86M-$2.92M-$2.72M
    Financing cash flow$133.22M-$1.21M$179.00K$16.32M
    Fiscal years ended Dec 2022 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
    Operating cash flow$15.14M$4.01M-$11.83M$21.38M$10.13M$2.86M-$16.12M-$6.49M$1.06M-$8.10M-$20.65M
    Capital expenditures$1.63M$1.66M$1.56M$1.35M$1.99M$1.25M$1.25M$969.00K$1.07M$1.04M$781.00K
    Free cash flow$13.51M$2.34M-$13.39M$20.03M$8.15M$1.61M-$17.37M-$7.46M-$12.00K-$9.15M-$21.43M
    Last 11 quarters

    Frequently Asked Questions About OMDA

    What is Omada Health, Inc. Common Stock's annual revenue?

    Omada Health, Inc. Common Stock reported revenue of $260.21M for the fiscal year ended Dec 31, 2025.

    How fast is Omada Health, Inc. Common Stock's revenue growing?

    Revenue was up 53.2% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 42.9%.

    Is Omada Health, Inc. Common Stock profitable?

    No. Omada Health, Inc. Common Stock reported net income of -$12.78M for the fiscal year ended Dec 31, 2025, with a net margin of -4.9%.

    How much free cash flow does OMDA generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $18.25M minus capital expenditures of $5.83M produced free cash flow of $12.42M.

    How much debt does Omada Health, Inc. Common Stock have?

    The balance sheet dated Dec 31, 2025 reported cash and equivalents of $222.04M.